Danaher (DHR) is a publicly traded Healthcare sector company. As of July 5, 2026, DHR trades at $197.93 with a market cap of $140.09B and a P/E ratio of 38.14. DHR moved +2.17% today. Year to date, DHR is -14.19%; over the trailing twelve months it is -2.26%. Its 52-week range spans $160.93 to $258.23. Analyst consensus is strong buy with an average price target of $228.80. Rallies surfaces DHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for DHR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $197.93 |
| Market Cap | $140.09B |
| P/E Ratio | 38.14 |
| EPS | $5.19 |
| Dividend Yield | 0.40% |
| 52-Week High | $258.23 |
| 52-Week Low | $160.93 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $24.78B |
| Net Income | $3.69B |
| Gross Margin | 58.94% |
22 analysts cover DHR: 0 strong buy, 18 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $228.80.